Long-term treatment with ligelizumab achieves prolonged symptom control in chronic spontaneous urticaria patients during the post-treatment follow-up

Weily Soong, Jonathan A Bernstein, Gordon Sussman, Bobby Lanier, Karl Sitz, Marcus Maurer, Ana Giménez-Arnau, Eva Hua, Avantika Barve, Thomas Severin, Reinhold Janocha

American Academy of Allergy, Asthma & Immunology 2020